<bill session="118" type="s" number="604" updated="2025-05-27T14:16:21Z">
  <state datetime="2023-03-01">REFERRED</state>
  <status>
    <introduced datetime="2023-03-01"/>
  </status>
  <introduced datetime="2023-03-01"/>
  <titles>
    <title type="display">Changing the Culture of the FDA Act</title>
    <title type="short" as="introduced">Changing the Culture of the FDA Act</title>
    <title type="official" as="introduced">A bill to direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.</title>
  </titles>
  <sponsor bioguide_id="M001183"/>
  <cosponsors>
    <cosponsor bioguide_id="B001310" joined="2023-03-01"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-01">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-01" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2023-07-20T17:37:01Z" status="Introduced in Senate">Changing the Culture of the FDA Act

This bill requires the Food and Drug Administration to amend its mission statement to state that it is responsible for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)</summary>
</bill>
